High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq
Clinical and Translational Medicine · 2026
DOI: 10.1002/ctm2.70584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2026. Verfasst von Qingmei Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: GMU-GIBH Joint School of Life Sciences, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: DNA Methylation, Single-Cell Analysis, Chromatin, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Guangzhou National Laboratory, the Guangdong Provincial Pearl River Talents Program, Guangzhou science and technology elite "pilot" project.
Abstract (Originalsprache)
Background
DNA methylation and chromatin accessibility are pivotal epigenetic regulators of gene expression and cellular identity, with significant implications in tumorigenesis and progression. Current single‐cell multi‐omics methods are limited in throughput and sensitivity, hindering comprehensive biomarker discovery.
Methods
We developed single‐cell split‐pool ligation‐based multi‐omics sequencing technology (SpliCOOL‐seq), a high‐throughput single‐cell sequencing technology that simultaneously profiles whole‐genome DNA methylation and chromatin accessibility in thousands of cells. By integrating in situ GpC methylation, universal Tn5 tagmentation, and split‐pool combinatorial barcoding, SpliCOOL‐seq achieves enhanced sensitivity and scalability.
Results
SpliCOOL‐seq accurately distinguished lung cancer cell types based on genetic and multiple epigenetic modalities and revealed that the two DNA methyltransferase (DNMT) inhibitors, 5‐Azacitidine and Decitabine, both cause large‐scale demethylation but in distinct patterns. Applied to primary lung adenocarcinoma, SpliCOOL‐seq identified tumour subclones within the tumour lesion and uncovered novel DNA methylation biomarkers (e.g., FAM124B, SFN, OR7E47P ) associated with patient survival. Additionally, we demonstrated accelerated epigenetic ageing and mitotic activity in tumour subclones, providing new insights into tumorigenesis.
Conclusion
SpliCOOL‐seq achieves parallel profiling of whole‐genome DNA methylation and chromatin accessibility in the same individual cells in a high‐throughput manner and is hopefully used to illustrate regulatory interactions under different cell states. SpliCOOL‐seq enables high‐resolution, multi‐modal epigenetic profiling at single‐cell resolution, offering a powerful platform for discovering cancer biomarkers. Its application reveals novel therapeutic targets and early‐diagnostic markers, underscoring its potential in precision oncology. Key points SpliCOOL‐seq achieves high‐throughput single‐cell co‐profiling of DNA methylation and chromatin accessibility. DNMT inhibitors caused cancer cell demethylation with divergent patterns. SpliCOOL‐seq enables the discovery of genes related to LUAD tumorigenesis. Ageing and LUAD tumorigenesis may share similar epigenetic alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GMU-GIBH Joint School of Life Sciences, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
- Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China.
- MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, C…
Förderung
- Major Project of Guangzhou National Laboratory
- the Guangdong Provincial Pearl River Talents Program
- Guangzhou science and technology elite "pilot" project
Zitieren
APA
Shen, Q., Deng, E., Luo, L., Zhang, J., Yang, Q., Su, D., & Fan, X. (2026). High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70584
Vancouver
Shen Q, Deng E, Luo L, Zhang J, Yang Q, Su D, et al. High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq. Clinical and Translational Medicine. 2026. doi:10.1002/ctm2.70584
BibTeX
@article{Shen2026,
author = {Shen, Qingmei and Deng, Enze and Luo, Ling and Zhang, Jingna and Yang, Qifeng and Su, Dan and Fan, Xiaoying},
title = {High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70584}
}
EUVIMED